A Bangladeshi pharma company will soon release a generic version of an expensive drug for cystic fibrosis that will allow hundreds of patients worldwide to access treatment.

The drug will cost around “$6,750 a year for adults, and around $2,000 per year for children.” This is compared to the current cost of treatment “priced between $300,000 and $370,000.”